Latest news We are a clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseasesTo learn more about Erytech's phase 3 clinical trial in pancreatic cancer> US Residents, click here> NON-US Residents, click hereTo learn more about Erytech's phase 2 clinical trial in Triple Negative Breast Cancer> Click here
